'Gliptin' Diabetes Drugs May Be Heart Savers

EASD 2011 — LISBON — While searching for potential cardiovascular risks among studies involving dipeptidyl peptidase-4 (DPP-4) inhibitors in type 2 diabetics, researchers made a surprising discovery -- treatment with the so-called gliptin class appears to protect the heart.


< Back to Listings